Persistent Asset Partners »

Castle Biosciences shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $96k 2.5k 38.90

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Rtw Investments
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
State Street Corporation
Geode Capital Management
Palisade Capital Management
AIGH Capital Management
Allianz Asset Management
Millennium Management
Daniel D. Thurber
Nuveen

View all funds holding Castle Biosciences